TGFβ family members and their downstream effector molecules have been widely demonstrated to be upregulated in various tumors, including NSCLC, and to play a vital role in tumor progression processes such as EMT, tumor immune escape, angiogenesis, chemoresistance, and metastasis (11, 13). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.